The initial field trials of DSM-5: new blooms and old thorns.

  title={The initial field trials of DSM-5: new blooms and old thorns.},
  author={Robert Freedman and David A. Lewis and Robert Michels and Daniel S. Pine and Susan K. Schultz and Carol A. Tamminga and Glen Owens Gabbard and Susan Shur-Fen Gau and Daniel C. Javitt and Maria A. Oquendo and Patrick E. Shrout and Eduard Vieta and Joel Yager},
  journal={The American journal of psychiatry},
  volume={170 1},
Three articles in this issue detail the process and results of reliability tests for proposed DSM-5 diagnoses and cross-diagnosis symptom domains. The editorial highlights the good reliability of borderline personality disorder and relates the questionable reliability of major depressive disorder to its heterogeneity. The editorial is also available in Spanish, Traditional Chinese, and Simplified Chinese. 

Figures from this paper

Somatic symptom disorder: an important change in DSM.

DSM-5: Basics and Critics

The next four chapters of the present work review the DSM-5 (American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorder. Washington, DC: American Psychiatric Association,

Mixed states in DSM-5: implications for clinical care, education, and research.

Diagnostic consistency and interchangeability of schizophrenic disorders and bipolar disorders: A 7‐year follow‐up study

In this study, a nationwide population‐based sample is used to compare the diagnostic consistency and interchange rate between schizophrenic disorders and bipolar disorders.

DSM-5: Challenging diagnostic testimony.

The next stage for diagnosis: validity through utility

  • P. McGorry
  • Psychology
    World psychiatry : official journal of the World Psychiatric Association
  • 2013
The publication of DSM-III in 1980 certainly represented a watershed in its appropriate bid to enhance reliability, but it is apparent that, despite the huge effort and expense devoted to its successors, it has hit a wall in terms of validity and utility.

The DSM-5 and the mental health clinician as consultant

In DSM-5, the categories have been reorganized and the diagnostic criteria revisited, and the authors integrated diagnoses Usually made in childhood or adolescence alongside similar diagnoses usually made in adulthood.

Psychiatric classification: Current debate and future directions.

A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders

Clinicians are encouraged to screen all patients presenting with a major depressive episode (or hypomanic episode) for MFS, and second generation antipsychotics and/or conventional mood stabilizers may be considered as first-line therapies for individuals with a depressive episode as part of MDD or BD with mixed features.

Dynamics of Decision-Making: The Issue of Reliability in Diagnosis

It is demonstrated that with the DSM, psychiatric diagnosis did not become more reliable, and the key problems that critical researchers had been addressing in the 1970s still remain unresolved.



Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

It was shown by follow-up and family studies that poor prognosis cases can be validly separated clinically from good prediction cases, and the authors conclude that good prognosis "schizophrenia" is not mild schizophrenia, but a different illness.

DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5.

These results show promising test-retest reliability results for this group of assessments, many of which are newly developed or have not been previously tested in psychiatric populations.

DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.

Most diagnoses adequately tested had good to very good reliability with these representative clinical populations assessed with usual clinical interview methods.

Antidepressant drug effects and depression severity: a patient-level meta-analysis.

The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms.

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

Remission was significantly less likely and took longer to occur in these patients than in those with nonanxious depression, and ratings of side effect frequency, intensity, and burden, as well as the number of serious adverse events, were significantly greater in the anxious depression group.

Personality disorders in DSM-5.

DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches.

Multisite field trials and training comparable to what would be available to any clinician after publication of DSM-5 provided “real-world” testing of DSM-5 proposed diagnoses.

Preface, in Psychiatric Diagnosis

  • 1974